LifeStance Health Group, Inc. (LFST)

From the record

LifeStance Health Group, Inc.'s filings since 2021 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

LifeStance Health Group, Inc.'s 6 filed years say what it did: revenue went from $213 million in fiscal 2019 to $1.4 billion in fiscal 2025, up 37.3% a year; it rose in 5 of 5 years; it never fell from a peak; net income was positive in 2 of 6 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, LifeStance Health Group, Inc.'s diluted share count grew about 3.3% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 36 sales (23 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-12 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, LifeStance Health Group, Inc. earned about 1 cents of profit for every dollar of shareholders' money. Leverage: it owed about 31 cents per dollar of assets, and net share issuance: its share count grew 3.2% over the year (the filed statements).

From the record

LifeStance Health Group, Inc.'s standing among 14 graded names in its industry family: revenue of $1.4 billion in fiscal 2025 ranks in the top 18% by size; a net margin of 0.7% ranks in the top 39%; revenue growth of 18.3% a year over the last 3 filed years ranks in the top 46% (its annual reports).

From the record

LifeStance Health Group, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Bourdon, David (Chief Executive Officer, as filed), filing under that title since 2025-03-10, 1.7 years (bottom 25% of its family); the 17 officers and directors filing in the last fifteen months have been on the record a median of 2.1 years (bottom 14%); 10 officer or director changes were reported on Form 8-K since 2023-11-13, against the 17 people in charge now (bottom 13%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

LifeStance Health Group, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $249 million against debt of $283 million leaves -1.5% of its assets as net cash, bottom 25% of its family; cash from operations less capital spending is 7.7% of revenue (top 18%) (its annual report).

From the record

LifeStance Health Group, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 18.3% a year over the last three filed years against 37.3% over all 6, slowing (bottom 32% of its family); the newest year grew 13.9% (bottom 18%); capital spending grew -23% a year (bottom 12%) (its annual reports). LifeStance Health Group, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

LifeStance Health Group, Inc.'s newest year against its own record: revenue of $1.4 billion in fiscal 2025 came in 5.6% below the $1.5 billion its prior three years' pace pointed to (bottom 21% of its family); net income of $10 million against a prior three-year average of $153 million (top 37%); a net margin of 0.7% against -15.8% before (top 37%) (its annual reports).